This study measured the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes.
Satyin Kaura, MSci, MBA
Advertisement
Articles by Satyin Kaura, MSci, MBA
Advertisement
Latest Updated Articles
- The Value of Survival Gains in Myelodysplastic Syndromes
Published: January 16th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
2
Promises and Pitfalls of AI in Health Care
3
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
4
Review Outlines Shared Pathways Between CKD, VHD
5
